| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Interleukin-13 | 39 | 2020 | 389 | 6.280 |
Why?
|
| Pulmonary Fibrosis | 26 | 2022 | 530 | 3.740 |
Why?
|
| Lectins | 18 | 2015 | 513 | 3.170 |
Why?
|
| Adipokines | 18 | 2015 | 320 | 2.910 |
Why?
|
| Lung | 68 | 2023 | 9857 | 2.720 |
Why?
|
| Transforming Growth Factor beta1 | 25 | 2022 | 644 | 2.650 |
Why?
|
| Glycoproteins | 19 | 2015 | 2266 | 2.610 |
Why?
|
| Th2 Cells | 18 | 2019 | 1061 | 2.310 |
Why?
|
| Hyperoxia | 12 | 2012 | 262 | 2.270 |
Why?
|
| Interleukin-13 Receptor alpha2 Subunit | 6 | 2020 | 14 | 2.190 |
Why?
|
| Chitin | 9 | 2018 | 41 | 2.080 |
Why?
|
| Pulmonary Alveoli | 16 | 2015 | 675 | 2.020 |
Why?
|
| Pulmonary Emphysema | 10 | 2022 | 672 | 1.640 |
Why?
|
| Mice, Transgenic | 69 | 2022 | 9735 | 1.640 |
Why?
|
| Asthma | 29 | 2023 | 6010 | 1.600 |
Why?
|
| Inflammation | 42 | 2023 | 10637 | 1.550 |
Why?
|
| Antibodies, Bispecific | 2 | 2022 | 164 | 1.440 |
Why?
|
| Airway Remodeling | 6 | 2016 | 132 | 1.420 |
Why?
|
| Respiratory Mucosa | 12 | 2021 | 427 | 1.410 |
Why?
|
| Vascular Endothelial Growth Factor A | 15 | 2017 | 3511 | 1.380 |
Why?
|
| Apoptosis | 26 | 2019 | 9724 | 1.290 |
Why?
|
| Interleukin-18 | 6 | 2021 | 249 | 1.250 |
Why?
|
| Hermanski-Pudlak Syndrome | 2 | 2018 | 22 | 1.160 |
Why?
|
| Hexosaminidases | 6 | 2021 | 54 | 1.130 |
Why?
|
| Mice, Inbred C57BL | 63 | 2022 | 21833 | 1.130 |
Why?
|
| Mice | 124 | 2023 | 81201 | 1.120 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 11 | 2022 | 3047 | 1.050 |
Why?
|
| Lung Injury | 6 | 2018 | 436 | 1.050 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 6 | 2023 | 451 | 1.050 |
Why?
|
| Angiopoietin-2 | 5 | 2012 | 172 | 1.020 |
Why?
|
| Melanoma, Experimental | 6 | 2021 | 561 | 1.000 |
Why?
|
| Receptors, Interleukin-13 | 4 | 2020 | 15 | 0.970 |
Why?
|
| Transforming Growth Factor beta | 15 | 2022 | 2007 | 0.960 |
Why?
|
| Mucus | 6 | 2008 | 321 | 0.960 |
Why?
|
| Interleukin-11 | 5 | 2008 | 63 | 0.940 |
Why?
|
| Animals | 143 | 2023 | 168768 | 0.930 |
Why?
|
| Epithelial Cells | 12 | 2021 | 3690 | 0.920 |
Why?
|
| Semaphorins | 3 | 2014 | 101 | 0.870 |
Why?
|
| Mice, Knockout | 37 | 2021 | 14561 | 0.830 |
Why?
|
| Bronchoalveolar Lavage Fluid | 15 | 2018 | 768 | 0.790 |
Why?
|
| Interferon-gamma | 9 | 2018 | 3207 | 0.760 |
Why?
|
| Cytokines | 16 | 2023 | 7323 | 0.740 |
Why?
|
| Antibodies, Neoplasm | 1 | 2021 | 286 | 0.730 |
Why?
|
| Th1 Cells | 6 | 2018 | 1057 | 0.690 |
Why?
|
| Lung Neoplasms | 9 | 2022 | 13104 | 0.670 |
Why?
|
| Antigens, CD | 6 | 2022 | 4026 | 0.670 |
Why?
|
| Emphysema | 6 | 2012 | 247 | 0.670 |
Why?
|
| Chemokines | 8 | 2009 | 970 | 0.590 |
Why?
|
| Immunity, Innate | 7 | 2023 | 2962 | 0.590 |
Why?
|
| Laminin | 1 | 2018 | 419 | 0.580 |
Why?
|
| Macrophages | 15 | 2022 | 5660 | 0.570 |
Why?
|
| Lung Diseases | 5 | 2011 | 1887 | 0.560 |
Why?
|
| Galectin 3 | 1 | 2018 | 227 | 0.550 |
Why?
|
| Adjuvants, Immunologic | 2 | 2012 | 1000 | 0.540 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 2010 | 306 | 0.530 |
Why?
|
| Disease Models, Animal | 34 | 2021 | 18034 | 0.520 |
Why?
|
| Melanoma | 4 | 2022 | 5511 | 0.520 |
Why?
|
| Cell Death | 10 | 2016 | 1707 | 0.510 |
Why?
|
| Bronchi | 3 | 2012 | 840 | 0.510 |
Why?
|
| In Situ Nick-End Labeling | 9 | 2014 | 644 | 0.510 |
Why?
|
| Signal Transduction | 28 | 2021 | 23404 | 0.510 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2013 | 816 | 0.510 |
Why?
|
| Macrophage Activation | 5 | 2018 | 560 | 0.490 |
Why?
|
| Matrix Metalloproteinase 12 | 4 | 2007 | 49 | 0.490 |
Why?
|
| Pulmonary Surfactants | 3 | 2008 | 162 | 0.490 |
Why?
|
| MAP Kinase Signaling System | 4 | 2016 | 1525 | 0.470 |
Why?
|
| Growth Substances | 2 | 2018 | 784 | 0.470 |
Why?
|
| Bronchial Hyperreactivity | 5 | 2010 | 319 | 0.460 |
Why?
|
| Receptors, CCR5 | 2 | 2006 | 498 | 0.460 |
Why?
|
| Interleukin-10 | 4 | 2012 | 1200 | 0.450 |
Why?
|
| Receptors, Interleukin | 2 | 2005 | 245 | 0.440 |
Why?
|
| Bleomycin | 8 | 2022 | 512 | 0.430 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2013 | 157 | 0.420 |
Why?
|
| Receptors, Chemokine | 3 | 2009 | 670 | 0.420 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2015 | 375 | 0.420 |
Why?
|
| Neoplasm Proteins | 2 | 2021 | 3707 | 0.420 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2015 | 985 | 0.400 |
Why?
|
| Endoribonucleases | 1 | 2013 | 229 | 0.400 |
Why?
|
| Adenosine | 3 | 2006 | 825 | 0.400 |
Why?
|
| Aminoglycosides | 2 | 2022 | 162 | 0.400 |
Why?
|
| Ovalbumin | 6 | 2009 | 719 | 0.400 |
Why?
|
| Gene Expression Regulation | 16 | 2019 | 12073 | 0.390 |
Why?
|
| Macrophages, Peritoneal | 2 | 2009 | 251 | 0.390 |
Why?
|
| Inflammation Mediators | 4 | 2011 | 1888 | 0.390 |
Why?
|
| P-Selectin | 1 | 2013 | 601 | 0.380 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2013 | 248 | 0.380 |
Why?
|
| DNA | 7 | 2007 | 7294 | 0.380 |
Why?
|
| Cathepsins | 3 | 2009 | 241 | 0.380 |
Why?
|
| DNA Helicases | 1 | 2016 | 861 | 0.370 |
Why?
|
| Pneumonia | 6 | 2016 | 2133 | 0.370 |
Why?
|
| Chemokines, CC | 4 | 2005 | 291 | 0.370 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2012 | 534 | 0.370 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2010 | 354 | 0.360 |
Why?
|
| Intra-Abdominal Fat | 1 | 2015 | 591 | 0.350 |
Why?
|
| Interferon Type I | 2 | 2011 | 542 | 0.350 |
Why?
|
| Chemokine CCL17 | 1 | 2009 | 23 | 0.340 |
Why?
|
| Nitric Oxide | 4 | 2014 | 2132 | 0.340 |
Why?
|
| Interleukin-17 | 3 | 2012 | 901 | 0.340 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2007 | 295 | 0.330 |
Why?
|
| Proto-Oncogene Proteins c-akt | 8 | 2023 | 2504 | 0.330 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 994 | 0.330 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2011 | 599 | 0.330 |
Why?
|
| Scleroderma, Systemic | 1 | 2012 | 323 | 0.320 |
Why?
|
| Fibrosis | 8 | 2022 | 2029 | 0.310 |
Why?
|
| Gene Expression | 9 | 2021 | 7798 | 0.310 |
Why?
|
| Poly I-C | 3 | 2016 | 115 | 0.310 |
Why?
|
| Muscle, Smooth | 1 | 2012 | 934 | 0.310 |
Why?
|
| Pneumococcal Infections | 1 | 2012 | 497 | 0.300 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2007 | 107 | 0.300 |
Why?
|
| Chitosan | 1 | 2008 | 141 | 0.300 |
Why?
|
| Autoantigens | 2 | 2009 | 892 | 0.300 |
Why?
|
| Receptors, Interleukin-18 | 1 | 2007 | 22 | 0.300 |
Why?
|
| Interleukin-6 | 6 | 2022 | 3203 | 0.300 |
Why?
|
| Matrix Metalloproteinases | 4 | 2016 | 391 | 0.300 |
Why?
|
| ADAM Proteins | 1 | 2008 | 243 | 0.290 |
Why?
|
| Membrane Proteins | 3 | 2021 | 7882 | 0.290 |
Why?
|
| Streptococcus pneumoniae | 1 | 2012 | 714 | 0.290 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2007 | 92 | 0.290 |
Why?
|
| Exocrine Glands | 1 | 2006 | 50 | 0.280 |
Why?
|
| Transgenes | 5 | 2006 | 1009 | 0.280 |
Why?
|
| Interleukin-4 | 4 | 2010 | 1147 | 0.280 |
Why?
|
| Physical Conditioning, Animal | 2 | 2020 | 354 | 0.280 |
Why?
|
| Matrix Metalloproteinase 9 | 4 | 2006 | 638 | 0.280 |
Why?
|
| Acute Lung Injury | 1 | 2010 | 380 | 0.280 |
Why?
|
| Smoke | 2 | 2010 | 227 | 0.280 |
Why?
|
| Endothelium | 2 | 2013 | 778 | 0.280 |
Why?
|
| DNA Damage | 5 | 2007 | 2432 | 0.280 |
Why?
|
| Fibroblasts | 9 | 2022 | 4162 | 0.280 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2014 | 772 | 0.270 |
Why?
|
| Allergens | 4 | 2010 | 1320 | 0.270 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2006 | 144 | 0.270 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2007 | 274 | 0.270 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2006 | 489 | 0.260 |
Why?
|
| Leukotrienes | 2 | 2006 | 255 | 0.260 |
Why?
|
| Adaptive Immunity | 1 | 2010 | 714 | 0.260 |
Why?
|
| Smoking | 5 | 2015 | 8987 | 0.250 |
Why?
|
| Humans | 91 | 2023 | 744366 | 0.250 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2018 | 4424 | 0.250 |
Why?
|
| Metalloendopeptidases | 2 | 2006 | 396 | 0.250 |
Why?
|
| 3' Untranslated Regions | 2 | 2019 | 513 | 0.250 |
Why?
|
| Delayed Graft Function | 2 | 2016 | 48 | 0.250 |
Why?
|
| Receptors, Cell Surface | 6 | 2016 | 2865 | 0.250 |
Why?
|
| Neovascularization, Pathologic | 3 | 2017 | 2638 | 0.240 |
Why?
|
| Muscle, Skeletal | 5 | 2022 | 4925 | 0.240 |
Why?
|
| Immunity, Cellular | 1 | 2010 | 1607 | 0.240 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2012 | 808 | 0.240 |
Why?
|
| Ceramides | 1 | 2005 | 199 | 0.240 |
Why?
|
| Dendritic Cells | 4 | 2015 | 2725 | 0.230 |
Why?
|
| Pulmonary Edema | 1 | 2006 | 414 | 0.230 |
Why?
|
| Macrophages, Alveolar | 4 | 2012 | 407 | 0.230 |
Why?
|
| RNA, Messenger | 14 | 2019 | 13035 | 0.230 |
Why?
|
| Host-Pathogen Interactions | 1 | 2012 | 1480 | 0.230 |
Why?
|
| STAT6 Transcription Factor | 5 | 2006 | 199 | 0.220 |
Why?
|
| Tetracycline | 2 | 2004 | 214 | 0.220 |
Why?
|
| Aging | 1 | 2021 | 8664 | 0.210 |
Why?
|
| Caspases | 5 | 2018 | 928 | 0.210 |
Why?
|
| MicroRNAs | 3 | 2019 | 3751 | 0.210 |
Why?
|
| Neoplasm Metastasis | 3 | 2021 | 4851 | 0.210 |
Why?
|
| Activated-Leukocyte Cell Adhesion Molecule | 1 | 2022 | 22 | 0.210 |
Why?
|
| Proteolipids | 1 | 2002 | 117 | 0.210 |
Why?
|
| Cell Line, Tumor | 6 | 2023 | 16690 | 0.210 |
Why?
|
| Fetal Proteins | 1 | 2022 | 94 | 0.210 |
Why?
|
| Growth Inhibitors | 1 | 2003 | 385 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2007 | 1434 | 0.200 |
Why?
|
| Early Growth Response Protein 1 | 3 | 2006 | 138 | 0.200 |
Why?
|
| Immediate-Early Proteins | 1 | 2004 | 453 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2020 | 1284 | 0.200 |
Why?
|
| Hypersensitivity | 3 | 2006 | 1102 | 0.200 |
Why?
|
| Protein Subunits | 1 | 2005 | 959 | 0.200 |
Why?
|
| Mice, Inbred Strains | 3 | 2018 | 1828 | 0.190 |
Why?
|
| Protein Kinases | 3 | 2018 | 1640 | 0.190 |
Why?
|
| Cell Proliferation | 9 | 2023 | 10483 | 0.190 |
Why?
|
| RNA, Small Interfering | 5 | 2019 | 3505 | 0.190 |
Why?
|
| Hexosyltransferases | 1 | 2020 | 53 | 0.190 |
Why?
|
| Infant, Premature | 1 | 2010 | 2045 | 0.190 |
Why?
|
| Immunohistochemistry | 9 | 2019 | 11366 | 0.190 |
Why?
|
| Cells, Cultured | 12 | 2019 | 19233 | 0.190 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2022 | 266 | 0.190 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2022 | 365 | 0.180 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 449 | 0.180 |
Why?
|
| Respiratory System | 2 | 2018 | 557 | 0.180 |
Why?
|
| Lymphokines | 1 | 2003 | 949 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2013 | 4751 | 0.180 |
Why?
|
| Oxygen | 4 | 2014 | 4189 | 0.170 |
Why?
|
| Hydrogen Peroxide | 1 | 2003 | 730 | 0.170 |
Why?
|
| Metaplasia | 3 | 2006 | 313 | 0.170 |
Why?
|
| Smad7 Protein | 1 | 2019 | 41 | 0.170 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2018 | 329 | 0.170 |
Why?
|
| Doxycycline | 6 | 2012 | 326 | 0.170 |
Why?
|
| Airway Obstruction | 1 | 2004 | 664 | 0.170 |
Why?
|
| Acute Kidney Injury | 3 | 2017 | 1968 | 0.170 |
Why?
|
| Genetic Techniques | 1 | 2002 | 435 | 0.170 |
Why?
|
| Receptors, Immunologic | 2 | 2015 | 1423 | 0.170 |
Why?
|
| Mastitis, Bovine | 1 | 2018 | 11 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 8432 | 0.160 |
Why?
|
| Lung Compliance | 3 | 2004 | 195 | 0.160 |
Why?
|
| Circadian Clocks | 1 | 2020 | 171 | 0.160 |
Why?
|
| Candidiasis | 1 | 2021 | 366 | 0.160 |
Why?
|
| Smad2 Protein | 1 | 2018 | 156 | 0.160 |
Why?
|
| Virus Internalization | 1 | 2022 | 502 | 0.160 |
Why?
|
| Recombinant Proteins | 2 | 2011 | 6621 | 0.160 |
Why?
|
| Inflammasomes | 2 | 2013 | 495 | 0.160 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2015 | 1213 | 0.150 |
Why?
|
| Immunoblotting | 3 | 2012 | 1683 | 0.150 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2022 | 536 | 0.150 |
Why?
|
| Airway Resistance | 2 | 2012 | 404 | 0.150 |
Why?
|
| Receptors, Interleukin-11 | 2 | 2008 | 3 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2014 | 3873 | 0.150 |
Why?
|
| Glycosylation | 1 | 2020 | 1128 | 0.150 |
Why?
|
| Acetaminophen | 1 | 2021 | 545 | 0.150 |
Why?
|
| Klebsiella Infections | 1 | 2018 | 138 | 0.150 |
Why?
|
| beta Catenin | 2 | 2023 | 1059 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2021 | 1157 | 0.150 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2022 | 496 | 0.150 |
Why?
|
| Interleukin-12 | 2 | 2010 | 580 | 0.140 |
Why?
|
| DNA Primers | 4 | 2007 | 2891 | 0.140 |
Why?
|
| Mice, Mutant Strains | 2 | 2012 | 1865 | 0.140 |
Why?
|
| Escherichia coli Infections | 2 | 2018 | 532 | 0.140 |
Why?
|
| Synaptotagmins | 1 | 2016 | 59 | 0.140 |
Why?
|
| Case-Control Studies | 8 | 2022 | 21748 | 0.140 |
Why?
|
| Muscular Atrophy | 1 | 2019 | 347 | 0.140 |
Why?
|
| Cell Line | 7 | 2021 | 16000 | 0.140 |
Why?
|
| Klebsiella pneumoniae | 1 | 2018 | 251 | 0.140 |
Why?
|
| Retinoid X Receptor beta | 1 | 2015 | 1 | 0.140 |
Why?
|
| Retinoid X Receptor gamma | 1 | 2015 | 5 | 0.140 |
Why?
|
| Chemokine CCL2 | 3 | 2023 | 619 | 0.140 |
Why?
|
| Hemorrhage | 1 | 2008 | 3461 | 0.140 |
Why?
|
| RNA Interference | 2 | 2016 | 2890 | 0.130 |
Why?
|
| Receptors, Prostaglandin | 1 | 2015 | 57 | 0.130 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2016 | 464 | 0.130 |
Why?
|
| Myofibroblasts | 1 | 2017 | 222 | 0.130 |
Why?
|
| STAT3 Transcription Factor | 2 | 2014 | 874 | 0.130 |
Why?
|
| Liver | 2 | 2021 | 7475 | 0.130 |
Why?
|
| Calgranulin B | 1 | 2015 | 84 | 0.130 |
Why?
|
| Interleukin-15 | 1 | 2015 | 184 | 0.130 |
Why?
|
| Oxygen Consumption | 1 | 2021 | 1868 | 0.130 |
Why?
|
| Interleukin-13 Receptor alpha1 Subunit | 2 | 2005 | 24 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2013 | 2505 | 0.120 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 2014 | 25 | 0.120 |
Why?
|
| Cryptococcosis | 1 | 2015 | 101 | 0.120 |
Why?
|
| Lung Diseases, Fungal | 1 | 2015 | 122 | 0.120 |
Why?
|
| Up-Regulation | 4 | 2018 | 4222 | 0.120 |
Why?
|
| Immunomodulation | 1 | 2018 | 541 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 4 | 2006 | 6386 | 0.120 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 850 | 0.120 |
Why?
|
| Fatigue | 1 | 2021 | 1531 | 0.120 |
Why?
|
| NIH 3T3 Cells | 2 | 2012 | 677 | 0.120 |
Why?
|
| Skin Neoplasms | 2 | 2018 | 5692 | 0.120 |
Why?
|
| Female | 32 | 2021 | 380193 | 0.120 |
Why?
|
| Immune Sera | 2 | 2004 | 641 | 0.120 |
Why?
|
| Mitochondria | 3 | 2018 | 3514 | 0.110 |
Why?
|
| Models, Biological | 8 | 2019 | 9584 | 0.110 |
Why?
|
| Peptide Hydrolases | 2 | 2007 | 634 | 0.110 |
Why?
|
| Pneumonia, Bacterial | 1 | 2016 | 316 | 0.110 |
Why?
|
| Endothelial Cells | 4 | 2017 | 3486 | 0.110 |
Why?
|
| Gene Silencing | 2 | 2014 | 1539 | 0.110 |
Why?
|
| Capillary Permeability | 2 | 2008 | 798 | 0.110 |
Why?
|
| Malaria, Cerebral | 1 | 2014 | 135 | 0.110 |
Why?
|
| Receptors, Virus | 1 | 2016 | 649 | 0.110 |
Why?
|
| Flow Cytometry | 6 | 2015 | 5974 | 0.110 |
Why?
|
| Cardiovascular Diseases | 3 | 2016 | 15160 | 0.110 |
Why?
|
| Obesity | 1 | 2015 | 12746 | 0.110 |
Why?
|
| Animals, Newborn | 3 | 2008 | 2726 | 0.110 |
Why?
|
| Arginase | 1 | 2012 | 79 | 0.110 |
Why?
|
| Dermatitis, Atopic | 1 | 2019 | 654 | 0.110 |
Why?
|
| Adenosine Deaminase | 2 | 2005 | 241 | 0.110 |
Why?
|
| Insulin Resistance | 2 | 2021 | 3864 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2014 | 552 | 0.110 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4208 | 0.100 |
Why?
|
| Respiratory Syncytial Viruses | 2 | 2018 | 165 | 0.100 |
Why?
|
| In Situ Hybridization | 3 | 2007 | 1950 | 0.100 |
Why?
|
| Nitric Oxide Synthase | 2 | 2006 | 915 | 0.100 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2012 | 85 | 0.100 |
Why?
|
| Oxidative Stress | 3 | 2013 | 3084 | 0.100 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2015 | 1369 | 0.100 |
Why?
|
| Organ Specificity | 3 | 2010 | 2008 | 0.100 |
Why?
|
| Pseudomonas Infections | 1 | 2016 | 613 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2013 | 689 | 0.100 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2022 | 1632 | 0.100 |
Why?
|
| Caspase 1 | 1 | 2012 | 224 | 0.100 |
Why?
|
| Uteroglobin | 3 | 2006 | 58 | 0.100 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2012 | 127 | 0.100 |
Why?
|
| Male | 29 | 2021 | 350115 | 0.100 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2013 | 300 | 0.100 |
Why?
|
| Gene Expression Profiling | 3 | 2018 | 9445 | 0.100 |
Why?
|
| Phenotype | 7 | 2016 | 16367 | 0.090 |
Why?
|
| Fibrinogen | 1 | 2014 | 894 | 0.090 |
Why?
|
| STAT4 Transcription Factor | 1 | 2010 | 96 | 0.090 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2012 | 237 | 0.090 |
Why?
|
| Serum Amyloid P-Component | 1 | 2010 | 47 | 0.090 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2011 | 91 | 0.090 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2018 | 1821 | 0.090 |
Why?
|
| Blood Platelets | 1 | 2021 | 2509 | 0.090 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2011 | 182 | 0.090 |
Why?
|
| Respiratory Insufficiency | 3 | 2005 | 1199 | 0.090 |
Why?
|
| Endopeptidases | 3 | 2003 | 772 | 0.090 |
Why?
|
| Delirium | 1 | 2022 | 1610 | 0.090 |
Why?
|
| Alzheimer Disease | 2 | 2022 | 8038 | 0.090 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2014 | 1159 | 0.090 |
Why?
|
| Down-Regulation | 4 | 2019 | 3001 | 0.090 |
Why?
|
| Hyaluronic Acid | 2 | 2005 | 491 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2011 | 130 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2006 | 480 | 0.090 |
Why?
|
| Myelin Proteins | 1 | 2010 | 215 | 0.090 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 9647 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 4 | 2017 | 6171 | 0.090 |
Why?
|
| B-Lymphocytes | 1 | 2003 | 4666 | 0.090 |
Why?
|
| Statistics, Nonparametric | 2 | 2014 | 2887 | 0.090 |
Why?
|
| Influenza A virus | 1 | 2013 | 456 | 0.090 |
Why?
|
| Random Allocation | 2 | 2012 | 2428 | 0.090 |
Why?
|
| Trans-Activators | 4 | 2004 | 2926 | 0.090 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 2016 | 675 | 0.090 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 2 | 2008 | 214 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 2 | 2016 | 4463 | 0.090 |
Why?
|
| Neutrophils | 2 | 2021 | 3721 | 0.090 |
Why?
|
| Kidney Transplantation | 2 | 2016 | 4251 | 0.090 |
Why?
|
| Colitis | 2 | 2015 | 1170 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2015 | 1783 | 0.090 |
Why?
|
| Molecular Imaging | 1 | 2016 | 828 | 0.080 |
Why?
|
| Protein Binding | 2 | 2013 | 9384 | 0.080 |
Why?
|
| Protease Inhibitors | 2 | 2004 | 791 | 0.080 |
Why?
|
| Bronchoalveolar Lavage | 2 | 2006 | 120 | 0.080 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2016 | 1219 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 2916 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 20824 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2016 | 15520 | 0.080 |
Why?
|
| STAT1 Transcription Factor | 2 | 2006 | 320 | 0.080 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 15535 | 0.080 |
Why?
|
| Enzyme Induction | 2 | 2007 | 475 | 0.080 |
Why?
|
| Escherichia coli | 2 | 2018 | 4217 | 0.080 |
Why?
|
| Mucin 5AC | 1 | 2008 | 93 | 0.080 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2009 | 298 | 0.080 |
Why?
|
| Glioma | 1 | 2023 | 3401 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2012 | 1677 | 0.080 |
Why?
|
| Infant, Newborn | 5 | 2010 | 25628 | 0.080 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2009 | 664 | 0.080 |
Why?
|
| Glioblastoma | 1 | 2023 | 3481 | 0.080 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 2019 | 0.080 |
Why?
|
| Collagen | 4 | 2016 | 2688 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 7721 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2022 | 2938 | 0.080 |
Why?
|
| eIF-2 Kinase | 1 | 2008 | 150 | 0.080 |
Why?
|
| Sepsis | 2 | 2014 | 2593 | 0.080 |
Why?
|
| Acute Disease | 3 | 2008 | 7147 | 0.070 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2008 | 190 | 0.070 |
Why?
|
| Killer Cells, Natural | 1 | 2016 | 2133 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2007 | 6366 | 0.070 |
Why?
|
| Disease Progression | 4 | 2014 | 13286 | 0.070 |
Why?
|
| Glutathione Reductase | 1 | 2006 | 25 | 0.070 |
Why?
|
| Bacterial Load | 2 | 2018 | 153 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2014 | 2751 | 0.070 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2007 | 215 | 0.070 |
Why?
|
| Giant Cell Arteritis | 1 | 2011 | 292 | 0.070 |
Why?
|
| Actins | 2 | 2004 | 2121 | 0.070 |
Why?
|
| Edema | 1 | 2011 | 789 | 0.070 |
Why?
|
| Phagocytosis | 1 | 2012 | 1539 | 0.070 |
Why?
|
| Molecular Weight | 1 | 2009 | 2255 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 365 | 0.070 |
Why?
|
| Intestinal Mucosa | 2 | 2015 | 3037 | 0.070 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 252 | 0.070 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2007 | 171 | 0.070 |
Why?
|
| Cytoprotection | 1 | 2007 | 210 | 0.070 |
Why?
|
| Immunoglobulin E | 2 | 2009 | 1463 | 0.070 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2006 | 180 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2006 | 67 | 0.070 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 12262 | 0.070 |
Why?
|
| Reperfusion Injury | 1 | 2013 | 1026 | 0.070 |
Why?
|
| Amniotic Fluid | 1 | 2008 | 370 | 0.070 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2006 | 119 | 0.070 |
Why?
|
| Lectins, C-Type | 1 | 2009 | 589 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 2027 | 0.070 |
Why?
|
| Ligands | 3 | 2012 | 3282 | 0.070 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2007 | 215 | 0.070 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2008 | 337 | 0.070 |
Why?
|
| Malaria, Falciparum | 1 | 2014 | 1077 | 0.070 |
Why?
|
| Annexin A5 | 1 | 2005 | 103 | 0.070 |
Why?
|
| Epidermal Growth Factor | 1 | 2008 | 709 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2009 | 1202 | 0.070 |
Why?
|
| Interleukin-11 Receptor alpha Subunit | 1 | 2005 | 15 | 0.070 |
Why?
|
| Cell Movement | 3 | 2009 | 5218 | 0.070 |
Why?
|
| Injections, Subcutaneous | 1 | 2007 | 667 | 0.070 |
Why?
|
| Complement C5a | 1 | 2005 | 107 | 0.060 |
Why?
|
| Neuropilin-1 | 1 | 2005 | 90 | 0.060 |
Why?
|
| Mice, Inbred CBA | 2 | 2002 | 448 | 0.060 |
Why?
|
| Base Sequence | 3 | 2007 | 12797 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 2019 | 5867 | 0.060 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 2355 | 0.060 |
Why?
|
| Viruses | 1 | 2008 | 375 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2004 | 12207 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 2917 | 0.060 |
Why?
|
| Influenza, Human | 1 | 2015 | 1479 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 2 | 2014 | 2725 | 0.060 |
Why?
|
| Receptors, CCR1 | 1 | 2004 | 33 | 0.060 |
Why?
|
| Microscopy, Electron | 2 | 2004 | 2646 | 0.060 |
Why?
|
| Survival Analysis | 3 | 2017 | 10252 | 0.060 |
Why?
|
| Cell Count | 1 | 2008 | 1856 | 0.060 |
Why?
|
| Neutralization Tests | 1 | 2006 | 758 | 0.060 |
Why?
|
| Kidney | 2 | 2017 | 7184 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 1656 | 0.060 |
Why?
|
| Early Diagnosis | 1 | 2009 | 1184 | 0.060 |
Why?
|
| Immunization | 1 | 2008 | 1256 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 2542 | 0.060 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2003 | 61 | 0.060 |
Why?
|
| Dinoprostone | 1 | 2006 | 601 | 0.060 |
Why?
|
| Lymphocyte Activation | 2 | 2015 | 5524 | 0.060 |
Why?
|
| Antigens | 1 | 2009 | 1466 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2007 | 1101 | 0.060 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2003 | 109 | 0.060 |
Why?
|
| ras Proteins | 1 | 2008 | 1060 | 0.060 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 1 | 2002 | 19 | 0.050 |
Why?
|
| Lung Volume Measurements | 1 | 2004 | 378 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2009 | 3702 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2002 | 32 | 0.050 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2023 | 131 | 0.050 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2023 | 91 | 0.050 |
Why?
|
| Mucoproteins | 1 | 2002 | 50 | 0.050 |
Why?
|
| Mink | 1 | 2002 | 44 | 0.050 |
Why?
|
| Autophagy | 2 | 2022 | 1297 | 0.050 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2002 | 65 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 3778 | 0.050 |
Why?
|
| Virus Diseases | 1 | 2008 | 711 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2021 | 697 | 0.050 |
Why?
|
| Trachea | 1 | 2008 | 1076 | 0.050 |
Why?
|
| Total Lung Capacity | 1 | 2002 | 143 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2023 | 8861 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 2012 | 1534 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2014 | 4459 | 0.050 |
Why?
|
| Species Specificity | 1 | 2006 | 2478 | 0.050 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2004 | 472 | 0.050 |
Why?
|
| Bronchioles | 1 | 2021 | 25 | 0.050 |
Why?
|
| Mucins | 1 | 2005 | 564 | 0.050 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2003 | 335 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2009 | 2016 | 0.050 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2014 | 1813 | 0.050 |
Why?
|
| Receptors, CCR2 | 1 | 2002 | 212 | 0.050 |
Why?
|
| Chloride Channels | 1 | 2002 | 227 | 0.050 |
Why?
|
| Smad3 Protein | 1 | 2021 | 180 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2003 | 813 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2008 | 2513 | 0.050 |
Why?
|
| Disaccharides | 1 | 2021 | 171 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11486 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2002 | 569 | 0.050 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2021 | 193 | 0.050 |
Why?
|
| Transfection | 1 | 2008 | 5895 | 0.050 |
Why?
|
| Muscle Development | 1 | 2022 | 271 | 0.050 |
Why?
|
| Algorithms | 1 | 2021 | 13882 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 647 | 0.050 |
Why?
|
| Macrophage-1 Antigen | 1 | 2021 | 290 | 0.050 |
Why?
|
| Adult | 9 | 2021 | 214052 | 0.040 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2019 | 17 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 2021 | 305 | 0.040 |
Why?
|
| Interleukins | 1 | 2004 | 791 | 0.040 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2021 | 297 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 2556 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2018 | 2076 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2012 | 2988 | 0.040 |
Why?
|
| Middle Aged | 10 | 2021 | 213390 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 5223 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2012 | 5023 | 0.040 |
Why?
|
| Aged | 9 | 2022 | 163288 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2002 | 673 | 0.040 |
Why?
|
| Polyadenylation | 1 | 2019 | 117 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2004 | 1125 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2002 | 692 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2016 | 53290 | 0.040 |
Why?
|
| Cell Extracts | 1 | 2018 | 138 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2009 | 3476 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2004 | 3144 | 0.040 |
Why?
|
| Methacholine Chloride | 2 | 2010 | 233 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2004 | 1351 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2002 | 1549 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2015 | 9145 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 4320 | 0.040 |
Why?
|
| Receptors, Interleukin-15 | 1 | 2015 | 16 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 17446 | 0.030 |
Why?
|
| Diabetes Mellitus | 2 | 2014 | 5749 | 0.030 |
Why?
|
| Incidence | 1 | 2014 | 20952 | 0.030 |
Why?
|
| Blotting, Western | 3 | 2014 | 5181 | 0.030 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2016 | 96 | 0.030 |
Why?
|
| Pyridines | 1 | 2007 | 2825 | 0.030 |
Why?
|
| Time Factors | 4 | 2006 | 40075 | 0.030 |
Why?
|
| Peptides | 1 | 2007 | 4410 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 1617 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2023 | 2617 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2012 | 687 | 0.030 |
Why?
|
| Micelles | 1 | 2016 | 203 | 0.030 |
Why?
|
| Antioxidants | 1 | 2003 | 1659 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2023 | 1376 | 0.030 |
Why?
|
| Antigens, Fungal | 1 | 2015 | 70 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2019 | 1547 | 0.030 |
Why?
|
| Lipopolysaccharides | 2 | 2014 | 2216 | 0.030 |
Why?
|
| Hospitalization | 1 | 2014 | 10259 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2011 | 3444 | 0.030 |
Why?
|
| Cryptococcus neoformans | 1 | 2015 | 119 | 0.030 |
Why?
|
| Salmonella Infections, Animal | 1 | 2014 | 65 | 0.030 |
Why?
|
| Coronary Disease | 1 | 2009 | 6077 | 0.030 |
Why?
|
| Receptor Cross-Talk | 1 | 2014 | 119 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2015 | 297 | 0.030 |
Why?
|
| Leukocytes | 1 | 2022 | 2045 | 0.030 |
Why?
|
| Plasmodium berghei | 1 | 2014 | 168 | 0.030 |
Why?
|
| Astrocytes | 1 | 2020 | 1273 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 11718 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 3 | 2021 | 9274 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2014 | 314 | 0.030 |
Why?
|
| Bacterial Adhesion | 1 | 2014 | 316 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 246 | 0.030 |
Why?
|
| Stem Cell Factor | 1 | 2013 | 219 | 0.030 |
Why?
|
| Cadaver | 1 | 2016 | 1337 | 0.030 |
Why?
|
| Cattle | 1 | 2018 | 3922 | 0.030 |
Why?
|
| Host-Parasite Interactions | 1 | 2014 | 295 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2012 | 162 | 0.030 |
Why?
|
| Proteome | 1 | 2022 | 1798 | 0.030 |
Why?
|
| Salmonella typhimurium | 1 | 2014 | 351 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2002 | 3493 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2016 | 2327 | 0.020 |
Why?
|
| Stroke | 1 | 2014 | 9981 | 0.020 |
Why?
|
| Insulin | 2 | 2021 | 6582 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3590 | 0.020 |
Why?
|
| Interleukin-12 Receptor beta 2 Subunit | 1 | 2010 | 1 | 0.020 |
Why?
|
| Clodronic Acid | 1 | 2010 | 60 | 0.020 |
Why?
|
| Plasma | 1 | 2014 | 575 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 1799 | 0.020 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2011 | 82 | 0.020 |
Why?
|
| Survival Rate | 1 | 2005 | 12788 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 972 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2014 | 982 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2012 | 743 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 4479 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2014 | 1655 | 0.020 |
Why?
|
| Vasodilation | 1 | 2014 | 944 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 625 | 0.020 |
Why?
|
| Child | 5 | 2019 | 77709 | 0.020 |
Why?
|
| Uganda | 1 | 2014 | 1237 | 0.020 |
Why?
|
| Rats | 1 | 2006 | 24252 | 0.020 |
Why?
|
| Korea | 1 | 2008 | 99 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 18111 | 0.020 |
Why?
|
| Glucose Clamp Technique | 1 | 2009 | 266 | 0.020 |
Why?
|
| Biopsy | 1 | 2021 | 6755 | 0.020 |
Why?
|
| Drug Design | 1 | 2014 | 1076 | 0.020 |
Why?
|
| APACHE | 1 | 2009 | 277 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 300 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2021 | 3188 | 0.020 |
Why?
|
| Tissue and Organ Procurement | 1 | 2016 | 896 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2010 | 527 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2020 | 3587 | 0.020 |
Why?
|
| Founder Effect | 1 | 2008 | 189 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2008 | 286 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 2700 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2009 | 694 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 1837 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2016 | 2241 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 25039 | 0.020 |
Why?
|
| ROC Curve | 1 | 2014 | 3528 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2007 | 791 | 0.020 |
Why?
|
| Pregnancy | 1 | 2008 | 29144 | 0.020 |
Why?
|
| Hyperinsulinism | 1 | 2009 | 415 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2014 | 2765 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2007 | 270 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2016 | 2926 | 0.020 |
Why?
|
| Pulmonary Ventilation | 1 | 2008 | 374 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 57776 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 2499 | 0.020 |
Why?
|
| Pyrroles | 1 | 2012 | 1146 | 0.020 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2005 | 112 | 0.020 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2007 | 282 | 0.020 |
Why?
|
| Infant | 2 | 2019 | 35134 | 0.020 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2005 | 90 | 0.020 |
Why?
|
| Anemia | 1 | 2014 | 1503 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2007 | 758 | 0.020 |
Why?
|
| Prognosis | 2 | 2016 | 29060 | 0.020 |
Why?
|
| Plasmodium falciparum | 1 | 2014 | 1732 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2019 | 41005 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 1862 | 0.020 |
Why?
|
| Malaria | 1 | 2014 | 1239 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2016 | 1905 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2013 | 4777 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2006 | 625 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 1912 | 0.010 |
Why?
|
| Age Factors | 1 | 2021 | 18373 | 0.010 |
Why?
|
| Genotype | 2 | 2008 | 12952 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 7182 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3595 | 0.010 |
Why?
|
| Indoles | 1 | 2012 | 1839 | 0.010 |
Why?
|
| Hydroxyproline | 1 | 2002 | 116 | 0.010 |
Why?
|
| Mortality | 1 | 2014 | 2864 | 0.010 |
Why?
|
| Flavonoids | 1 | 2006 | 443 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
| Adolescent | 2 | 2008 | 85779 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2005 | 547 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2004 | 1581 | 0.010 |
Why?
|
| Neoplasms | 1 | 2011 | 21696 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2010 | 2441 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 14723 | 0.010 |
Why?
|
| Mutation | 1 | 2005 | 29786 | 0.010 |
Why?
|
| Monocytes | 1 | 2010 | 2596 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2007 | 2373 | 0.010 |
Why?
|
| Homozygote | 1 | 2005 | 1787 | 0.010 |
Why?
|
| Bronchodilator Agents | 1 | 2004 | 502 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 2050 | 0.010 |
Why?
|
| Respiratory Mechanics | 1 | 2004 | 686 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2012 | 4386 | 0.010 |
Why?
|
| Virus Replication | 1 | 2006 | 2535 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 19905 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 15078 | 0.010 |
Why?
|
| Critical Care | 1 | 2009 | 2647 | 0.010 |
Why?
|
| RNA | 1 | 2006 | 2749 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 2009 | 3680 | 0.010 |
Why?
|
| Length of Stay | 1 | 2009 | 6311 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2009 | 5316 | 0.010 |
Why?
|
| Swine | 1 | 2005 | 5918 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 3799 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2002 | 1741 | 0.010 |
Why?
|
| Hypertension | 1 | 2014 | 8479 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2014 | 40559 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2006 | 5101 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2009 | 11726 | 0.000 |
Why?
|
| Risk Factors | 1 | 2008 | 72296 | 0.000 |
Why?
|